 | • レポートコード：C-GIR20G2560 • 出版社/出版日：GlobalInfoResearch / 2019年12月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「乳がん診断及び薬物技術の世界市場2019年」は、グローバルにおける乳がん診断及び薬物技術市場を展望するレポートです。乳がん診断及び薬物技術のグローバル市場概観、企業動向、企業別シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどを掲載しています。 ・乳がん診断及び薬物技術の市場概観 ・乳がん診断及び薬物技術の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乳がん診断及び薬物技術の企業別販売動向、市場シェア、市場集中度、競争動向 ・乳がん診断及び薬物技術の世界市場規模 ・乳がん診断及び薬物技術の北米市場分析（アメリカ、カナダ、メキシコ等） ・乳がん診断及び薬物技術のアメリカ市場規模推移 ・乳がん診断及び薬物技術のカナダ市場規模推移 ・乳がん診断及び薬物技術のメキシコ市場規模推移 ・乳がん診断及び薬物技術のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・乳がん診断及び薬物技術のドイツ市場規模推移 ・乳がん診断及び薬物技術のイギリス市場規模推移 ・乳がん診断及び薬物技術のロシア市場規模推移 ・乳がん診断及び薬物技術のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・乳がん診断及び薬物技術の日本市場規模推移 ・乳がん診断及び薬物技術の中国市場規模推移 ・乳がん診断及び薬物技術の韓国市場規模推移 ・乳がん診断及び薬物技術のインド市場規模推移 ・乳がん診断及び薬物技術の東南アジア市場規模推移 ・乳がん診断及び薬物技術の南米市場分析（ブラジル、アルゼンチン等） ・乳がん診断及び薬物技術の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・乳がん診断及び薬物技術の種類別分析/販売量、売上、市場シェア（マンモグラフィ、生検、その他） ・乳がん診断及び薬物技術の用途別分析/市場規模（乳管癌、浸潤性乳管がん、小葉癌、トリプルネガティブ乳がん） ・乳がん診断及び薬物技術の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・乳がん診断及び薬物技術の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Breast Cancer Diagnostic and Drug Technologies market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Breast Cancer Diagnostic and Drug Technologies.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Breast Cancer Diagnostic and Drug Technologies market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Breast Cancer Diagnostic and Drug Technologies market by product type and applications/end industries.
Market Segment by Companies, this report covers
Philips
PerkinElmer
Becton Dickinson
Roche
Abbott
BioMerieux
Hologic
GE Healthcare
Quest Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Mammography
Biopsy
Other
Market Segment by Applications, can be divided into
Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer
Table of Contents
1 Breast Cancer Diagnostic and Drug Technologies Market Overview
1.1 Product Overview and Scope of Breast Cancer Diagnostic and Drug Technologies
1.2 Classification of Breast Cancer Diagnostic and Drug Technologies by Types
1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue Comparison by Types (2019-2024)
1.2.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Types in 2018
1.2.3 Mammography
1.2.4 Biopsy
1.2.5 Other
1.3 Global Breast Cancer Diagnostic and Drug Technologies Market by Application
1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Ductal Carcinoma of Breast
1.3.3 Invasive Ductal Carcinoma
1.3.4 Lobular Carcinoma
1.3.5 Triple Negative Breast Cancer
1.4 Global Breast Cancer Diagnostic and Drug Technologies Market by Regions
1.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Breast Cancer Diagnostic and Drug Technologies Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Breast Cancer Diagnostic and Drug Technologies Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breast Cancer Diagnostic and Drug Technologies Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Breast Cancer Diagnostic and Drug Technologies Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breast Cancer Diagnostic and Drug Technologies Status and Prospect (2014-2024)
1.5 Global Market Size of Breast Cancer Diagnostic and Drug Technologies (2014-2024)
2 Company Profiles
2.1 Philips
2.1.1 Business Overview
2.1.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Philips Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.2 PerkinElmer
2.2.1 Business Overview
2.2.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.3 Becton Dickinson
2.3.1 Business Overview
2.3.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.5 Abbott
2.5.1 Business Overview
2.5.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Abbott Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.6 BioMerieux
2.6.1 Business Overview
2.6.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.7 Hologic
2.7.1 Business Overview
2.7.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hologic Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.8 GE Healthcare
2.8.1 Business Overview
2.8.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
2.9 Quest Diagnostics
2.9.1 Business Overview
2.9.2 Breast Cancer Diagnostic and Drug Technologies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
3 Global Breast Cancer Diagnostic and Drug Technologies Market Competition, by Players
3.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Breast Cancer Diagnostic and Drug Technologies Players Market Share
3.2.2 Top 10 Breast Cancer Diagnostic and Drug Technologies Players Market Share
3.3 Market Competition Trend
4 Global Breast Cancer Diagnostic and Drug Technologies Market Size by Regions
4.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue and Market Share by Regions
4.2 North America Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
4.3 Europe Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
4.5 South America Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
5 North America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries
5.1 North America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
5.2 USA Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
5.3 Canada Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
5.4 Mexico Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
6 Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Countries
6.1 Europe Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
6.2 Germany Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
6.3 UK Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
6.4 France Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
6.5 Russia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
6.6 Italy Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Countries
7.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
7.2 China Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
7.3 Japan Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
7.4 Korea Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
7.5 India Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
8 South America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries
8.1 South America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
8.2 Brazil Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
8.3 Argentina Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
8.4 Colombia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Breast Cancer Diagnostic and Drug Technologies by Countries
9.1 Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
9.2 Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
9.3 UAE Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
9.4 Egypt Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
9.5 Nigeria Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
9.6 South Africa Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
10 Global Breast Cancer Diagnostic and Drug Technologies Market Segment by Type
10.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue and Market Share by Type (2014-2019)
10.2 Global Breast Cancer Diagnostic and Drug Technologies Market Forecast by Type (2019-2024)
10.3 Mammography Revenue Growth Rate (2014-2024)
10.4 Biopsy Revenue Growth Rate (2014-2024)
10.5 Other Revenue Growth Rate (2014-2024)
11 Global Breast Cancer Diagnostic and Drug Technologies Market Segment by Application
11.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Application (2014-2019)
11.2 Breast Cancer Diagnostic and Drug Technologies Market Forecast by Application (2019-2024)
11.3 Ductal Carcinoma of Breast Revenue Growth (2014-2019)
11.4 Invasive Ductal Carcinoma Revenue Growth (2014-2019)
11.5 Lobular Carcinoma Revenue Growth (2014-2019)
11.6 Triple Negative Breast Cancer Revenue Growth (2014-2019)
12 Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2024)
12.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast (2019-2024)
12.2 Global Breast Cancer Diagnostic and Drug Technologies Market Forecast by Regions (2019-2024)
12.3 North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
12.4 Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
12.6 South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Breast Cancer Diagnostic and Drug Technologies Picture
Table Product Specifications of Breast Cancer Diagnostic and Drug Technologies
Table Global Breast Cancer Diagnostic and Drug Technologies and Revenue (Million USD) Market Split by Product Type
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Types in 2018
Figure Mammography Picture
Figure Biopsy Picture
Figure Other Picture
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Application (2014-2024)
Figure Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Applications in 2018
Figure Ductal Carcinoma of Breast Picture
Figure Invasive Ductal Carcinoma Picture
Figure Lobular Carcinoma Picture
Figure Triple Negative Breast Cancer Picture
Table Global Market Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (2014-2024)
Table Philips Basic Information, Manufacturing Base and Competitors
Table Philips Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Philips Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table PerkinElmer Basic Information, Manufacturing Base and Competitors
Table PerkinElmer Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Roche Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Abbott Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table BioMerieux Basic Information, Manufacturing Base and Competitors
Table BioMerieux Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Hologic Basic Information, Manufacturing Base and Competitors
Table Hologic Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Hologic Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table GE Healthcare Basic Information, Manufacturing Base and Competitors
Table GE Healthcare Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Quest Diagnostics Basic Information, Manufacturing Base and Competitors
Table Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Type and Applications
Table Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2017-2018)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Players (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players in 2017
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players in 2018
Figure Global Top 5 Players Breast Cancer Diagnostic and Drug Technologies Revenue Market Share in 2018
Figure Global Top 10 Players Breast Cancer Diagnostic and Drug Technologies Revenue Market Share in 2018
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Regions (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Regions (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Regions (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Regions in 2018
Figure North America Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure South America Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table North America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
Table North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries in 2018
Figure USA Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Canada Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Mexico Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table Europe Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Countries (2014-2019)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries in 2018
Figure Germany Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure UK Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure France Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Russia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Italy Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries in 2018
Figure China Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Japan Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Korea Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure India Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table South America Breast Cancer Diagnostic and Drug Technologies Revenue by Countries (2014-2019)
Table South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries in 2018
Figure Brazil Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Argentina Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Colombia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Countries in 2018
Figure Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure UAE Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Egypt Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure Nigeria Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Figure South Africa Breast Cancer Diagnostic and Drug Technologies Revenue and Growth Rate (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) by Type (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Type (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Type (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Type in 2018
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Forecast by Type (2019-2024)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share Forecast by Type (2019-2024)
Figure Global Mammography Revenue Growth Rate (2014-2019)
Figure Global Biopsy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue by Application (2014-2019)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application in 2018
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue Forecast by Application (2019-2024)
Figure Global Breast Cancer Diagnostic and Drug Technologies Market Share Forecast by Application (2019-2024)
Figure Global Ductal Carcinoma of Breast Revenue Growth Rate (2014-2019)
Figure Global Invasive Ductal Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Lobular Carcinoma Revenue Growth Rate (2014-2019)
Figure Global Triple Negative Breast Cancer Revenue Growth Rate (2014-2019)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Breast Cancer Diagnostic and Drug Technologies Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
Figure Europe Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
Figure South America Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Revenue Market Forecast (2019-2024)
乳がん検査の世界市場 2019年版：種類別（スクリーニングテスト、診断テスト、モニタリングテスト）、用途別（非浸潤性乳がん、浸潤性乳がん） Scope of the Report: The global Breast Cancer Testing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, als…- 乳がん液体生検市場：世界及び中国市場分析・予測（～2024年） Breast Cancer Liquid Biopsy Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Breast Cancer Liquid Biopsy industry with a focus on the Chinese market. The report provides key statistics on the market status of the Breast Cancer …
- 世界の男性乳癌治療市場予測（～2024年） Male breast cancer (male breast neoplasm) is a rare cancer in males that originates from the breast. Many males with breast cancer have inherited a BRCA mutation, but there are other causes, including alcohol abuse and exposure to certain hormones and ionizing radiation. Scope of the Report: The glo…
- ホルモン抵抗性乳がんの世界市場 2019年版：種類別（腫瘍マーカー療法、遺伝子発現療法、遺伝子突然変異療法）、用途別（科学研究および生産、生物科学技術、医療技術、医療機器および器具） Scope of the Report: The global Hormone Refractory Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…
- 膵臓がん診断装置の世界市場 2019年版：種類別（イメージング、腫瘍バイオマーカー、生検、その他）、用途別（病院、クリニック、その他） Scope of the Report: The global Pancreatic Cancer Diagnostic Devices market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…